On April 3, 2025, Vera Therapeutics, Inc. (Nasdaq: VERA) in Brisbane, California, disclosed granting inducement awards to sixteen (16) new employees. These awards include non-qualified stock options for 211,250 shares of Class A common stock and restricted stock units (RSUs) for 105,125 shares of Class A common stock. The Compensation Committee approved these awards under the Inducement Plan as a material inducement for the new employees’ employment, complying with Nasdaq Listing Rule 5635(c)(4).